Deep, stable and durable reductions in kallikrein observed Among 32 patients who received a 50 mg dose of lonvo-z as of data ...

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced positive results from the pivotal Phase 3 CORE and CORE2 studies ...

Monthly olezarsen reduced triglycerides by 65% for people with severe hypertriglyceridemia, resulting in a greater than 85% ...

These data were presented today during a late-breaking session at the American Heart Association (AHA) Scientific Sessions and published simultaneously in The New England Journal of Medicine (NEJM) in ...

The Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control Organisation (CDSCO) has granted ...

When the usual suspects struggled against upset-conscious Terrafirma, TNT found an unlikely chief gunner in defensive ...

Make fall entertaining a breeze this year, regardless of the occasion, with warm, satisfying sides that serve a crowd like ...

ATH434 improves daily function and reduces brain iron in patients with multiple system atrophy, a rare, fatal ...

A pooled analysis of two phase 3 clinical trials shows that the first-in-class drug improves itching and itching-related ...

The First World War saw millions of soldiers killed and wounded on both sides, and many British troops did something unusual ...

I know we’re not an organization or a fanbase that makes excuses … but it’s a part of the learning curve and process.” ...

Proof-of-concept trials confirm robust anti-clotting effects for Regeneron’s two mechanistically-distinct antibodies against factor XI, in ...